The mGluR theory of fragile X mental retardation

Trends in Neurosciences
Mark F BearStephen T Warren

Abstract

Many of the diverse functional consequences of activating group 1 metabotropic glutamate receptors require translation of pre-existing mRNA near synapses. One of these consequences is long-term depression (LTD) of transmission at hippocampal synapses. Loss of fragile X mental retardation protein (FMRP), the defect responsible for fragile X syndrome in humans, increases LTD in mouse hippocampus. This finding is consistent with the growing evidence that FMRP normally functions as a repressor of translation of specific mRNAs. Here we present a theory that can account for diverse neurological and psychiatric aspects of fragile X syndrome, based on the assumption that many of the protein-synthesis-dependent functions of metabotropic receptors are exaggerated in fragile X syndrome. The theory suggests new directions for basic research as well as novel therapeutic approaches for the treatment of humans with fragile X, the most frequent inherited cause of mental retardation and an identified cause of autism.

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S M Dudek, M F Bear
Dec 1, 1991·American Journal of Medical Genetics·V J HintonR D Rudelli
Jan 1, 1989·Annual Review of Neuroscience·M Ito
Dec 20, 1974·Science·D P Purpura
Jan 1, 1994·Experimental Brain Research·Z I Bashir, G L Collingridge
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·I J Weiler, W T Greenough
Aug 9, 1996·American Journal of Medical Genetics·J M GodfraindP J Willems
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·I J WeilerW T Greenough
Oct 1, 1998·Neurobiology of Learning and Memory·A M Graybiel
Dec 10, 1999·British Journal of Pharmacology·H Z HuJ D Wood
Sep 28, 2000·Cerebral Cortex·W E Kaufmann, H W Moser
Feb 7, 2001·Human Molecular Genetics·B LaggerbauerU Fischer
Jun 30, 2001·Trends in Pharmacological Sciences·W P SpoorenR Kuhn
Oct 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·C Job, J Eberwine
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Peter W Vanderklish, Gerald M Edelman
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kimberly M HuberMark F Bear
Oct 2, 2002·Neuron·Stanislav S ZakharenkoSteven A Siegelbaum
Oct 9, 2002·Genes & Development·Amy A CaudyScott M Hammond
Oct 9, 2002·Genes & Development·Akira IshizukaHaruhiko Siomi
Mar 14, 2003·Trends in Biochemical Sciences·Peng Jin, Stephen T Warren
Oct 4, 2003·Cytogenetic and Genome Research·C E Bakker, B A Oostra
Oct 15, 2003·Neuron·Oswald Steward, Erin M Schuman
Nov 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Peter K ToddJames S Malter
Nov 25, 2003·Current Opinion in Pediatrics·Pietro ChiurazziBen A Oostra
Dec 23, 2003·The European Journal of Neuroscience·S A BrodyM A Geyer
Mar 19, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Laura N AntarGary J Bassell

❮ Previous
Next ❯

Citations

Sep 4, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jeremy Veenstra-VanderWeele, Zachary Warren
Jun 12, 2012·Neural Plasticity·Saul S Siller, Kendal Broadie
Nov 26, 2013·Journal of Autism and Developmental Disorders·Craig A EricksonBryan H King
Sep 21, 2013·Journal of Autism and Developmental Disorders·Craig A EricksonChristopher J McDougle
Jul 20, 2012·Neural Plasticity·Brandon S Martin, Molly M Huntsman
Jan 17, 2014·Nature Reviews. Genetics·Michael RonemusMichael Wigler
Aug 10, 2011·Neural Plasticity·Jocelyn J LeBlanc, Michela Fagiolini
Dec 3, 2013·Psychopharmacology·Jacob A S VorstmanJan K Buitelaar
Jan 15, 2014·Psychopharmacology·Kristel T E KleijerJ Peter H Burbach
Jul 4, 2013·CNS Drugs·Alberto C S Costa, Jonah J Scott-McKean
Dec 8, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kevin Miyashiro, James Eberwine
Feb 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Armaz AschrafiPeter W Vanderklish
Dec 19, 2013·Neurochemical Research·Ferzin SethnaHongbing Wang
Sep 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mika NakamotoStephen T Warren
Feb 21, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tao ChenMin Zhuo
Apr 10, 2014·Brain Research·Crystal T EngineerMichael P Kilgard
Nov 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Maija CastrénKarl Akerman
Dec 18, 2013·Proceedings of the National Academy of Sciences of the United States of America·Indulekha P SudhakaranMani Ramaswami
Feb 9, 2007·Proceedings of the National Academy of Sciences of the United States of America·Brian M Wilson, Charles L Cox
Nov 26, 2010·Annual Review of Medicine·Dilja D Krueger, Mark F Bear
Feb 5, 2014·Journal of Neural Transmission·Andreas G ChiocchettiChristine M Freitag
Aug 14, 2012·Neural Plasticity·Hansen Wang, Laurie C Doering
Sep 2, 2014·Nature Reviews. Drug Discovery·P Jeffrey ConnColleen M Niswender
Aug 12, 2014·Molecular and Cellular Neurosciences·Emily E StackpoleJustin R Fallon
May 31, 2014·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Inga Sophia KnothSarah Lippé
Nov 1, 2013·Psychopharmacology·Sébastien JacquemontBaltazar Gomez-Mancilla
Aug 1, 2014·Orphanet Journal of Rare Diseases·Betty HébertSylvain Briault
Sep 9, 2010·Annual Review of Genomics and Human Genetics·Hans Hilger Ropers
Apr 10, 2012·Annual Review of Neuroscience·Asha L BhakarMark F Bear
Oct 25, 2011·Annual Review of Pathology·Michael R SantoroStephen T Warren
Sep 13, 2014·Current Psychiatry Reports·John J Connolly, Hakon Hakonarson
Aug 7, 2010·American Journal on Intellectual and Developmental Disabilities·Agustini UtariDanh V Nguyen
May 28, 2013·Molecular Autism·Talakad G LohithRobert B Innis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.